Article

Clofazimine treatment modulates key non-coding RNAs associated with tumor progression and drug resistance in lethal Prostate Cancer

2025-02-25

Abstract excerpt

<h4>ABSTRACT</h4> Prostate cancer (PCa) is the most commonly diagnosed cancer and the second-leading cause of cancer death among men in the United States, representing 24.3% of all new cancer cases in the US. Metastatic castration-resistant prostate cancer (mCRPC) is a clinically advanced form of PCa that is associated with increased aggressiveness, cancer stemness, morbidity, and the risk of developing resistanc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: acfc8828-1fbc-52ee-8adb-936339562361
DOI: 10.1101/2025.02.20.25322381

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clofazimine treatment modulates key non-coding RNAs associated with tumor progression and drug resistance in lethal Prostate CancerDOI 10.1101/2025.02.20.25322381Read

Integrating pharmacogenomics data-driven prediction with bulk and single-cell RNAseq to demonstrate the efficacy of an NAMPT inhibitor against aggressive, taxane-resistant, and stem-like cells in lethal prostate cancerSemantic proximity Read

An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancerSemantic proximity Read

MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancerSemantic proximity Read

Exploration and Identification of Potential Therapeutic Targets and Biomarkers for Docetaxel Resistant Prostate CancerSemantic proximity Read

Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactionsSemantic proximity Read

Transcriptional mediators of treatment resistance in lethal prostate cancerSemantic proximity Read

Liquid-biopsy transcriptomic profiling uncovers molecular mediators of resistance to androgen receptor signaling inhibition in lethal prostate cancerSemantic proximity Read

Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancerSemantic proximity Read

Understanding the development of enzalutamide resistance based on a functional single-cell approachSemantic proximity Read

Resolving the immune landscape of human prostate at a single-cell level in health and cancerSemantic proximity Read

Single-cell analysis supports key cell subpopulations for drug resistance and metastasis in prostate cancerSemantic proximity Read

The mechanistic role of long non-coding RNAs in advanced prostate cancer response to therapySemantic proximity Read